5913 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1735)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2526)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5913)
  2. GSK Faculty (5696)
  3. Department of Medicine (4258)
  4. Department of Pathology and Laboratory Medicine (3036)
  5. Tow Center for Developmental Oncology (TCDO) (2612)
  6. Solid Tumor Oncology Division (2599)

More Groups

People
  1. Marc Ladanyi (1326)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (119)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (262)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (757)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5913)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy
    Journal Article

    Hoff, F. W.; Blum, W. G.; Huang, Y.; Welkie, R. L.; Swords, R. T.; Traer, E.; Stein, E. M.; Lin, T. L.; Archer, K. J.; Patel, P. A.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genomic and clinical characterization of non-invasive papillary urothelial carcinoma
    Meeting Abstract

    Gurbuz, B. C.; Caraballo, B.; Tallman, J.; Koll, F.; Basar, M.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Spatial profiling of urothelial carcinoma with aberrant histology identified significant intratumoral molecular and immune heterogeneity with clinical implications
    Meeting Abstract

    Kuo, F.; Basar, M.; Koll, F.; Chen, J. F.; Sarungbam, J.; Sirintrapun, S. J.; Chen, Y. B.; Gopalan, A.; Fine, S.; Tickoo, S.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • RB1 somatic alterations in ER-positive breast cancer: assessment of neuroendocrine differentiation
    Meeting Abstract

    Schwartz, C.; Marra, A.; Selenica, P.; da Silva, E. M.; Chandarlapaty, S.; Brogi, E.; Pareja, F.; Wen, H.
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • Production of alarmins S100a8/A9 by DNMT3A-mutant hematopoietic cells causes mesenchymal stromal cell senescence and seeds a pro-inflammatory environment in clonal hematopoiesis
    Meeting Abstract

    Mistry, J.; Young, K.; Maestre, I. F.; Levine, R.; Trowbridge, J.
    Experimental Hematology (2024)

    Fulltext@MSK | Save
  • The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?
    Review

    van den Bent, M. J.; French, P. J.; Brat, D.; Tonn, J. C.; Touat, M.; Ellingson, B. M.; Young, R. J.; Pallud, J.; von Deimling, A.; Sahm, F.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function
    Journal Article

    Le Luduec, J. B.; Kontopoulos, T.; Panjwani, M. K.; Sottile, R.; Liu, H.; Schäfer, G.; Massalski, C.; Lange, V.; Hsu, K. C.
    Blood Advances (2024)

    Fulltext@MSK | Save
  • The INSIGHT study: A randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations
    Journal Article

    George, S.; Blay, J. Y.; Chi, P.; Jones, R. L.; Serrano, C.; Somaiah, N.; Gelderblom, H.; Zalcberg, J. R.; Reichmann, W.; Sprott, K.; more...
    Future Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors
    Journal Article

    Offin, M.; Aguirre, N.; Yang, S. R.; Sauter, J. L.; Karagkounis, G.; Mohamed, M.; Cercek, A.; Kundra, R.; Zhang, Y.; Wang, H. M.; more...
    Annals of Surgical Oncology (2024)

    Fulltext@MSK | Save
  • ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
    Journal Article

    Taniguchi, H.; Chakraborty, S.; Takahashi, N.; Banerjee, A.; Caeser, R.; Zhan, Y. A.; Tischfield, S. E.; Chow, A.; Nguyen, E. M.; Villalonga, Á Q.; more...
    Science Advances (2024)

    Fulltext@MSK | Save